RPMI Railpen has funded part of the £84.4m in new capital raised by biotech company Oxford Nanopore Technologies.
The company - which has had several successful capital raises this year - is behind the Covid-19 test, Lampore, which has received regulatory approval in the UK and produces results within 90 minut...
To continue reading this article...
Join Professional Pensions
Become a Professional Pensions Lite Member today
In just a few clicks you can start your free Professional Pensions Lite membership for 12 months, providing you access to:
- Three complimentary articles per month covering the latest real-time news, analysis and opinion from the industry
- Receive important and breaking news stories via our two daily news alerts
- Hear from industry experts and other forward-thinking leaders
